Cargando…
Retrospective Data Analysis of Patients With Metastatic Lung Adenocarcinoma With or Without KRAS-Mutation or TTF1-Expression
INTRODUCTION: Patients with lung adenocarcinoma not expressing TTF1 and those with a KRAS mutation have worse prognosis. However, available data are limited and sometimes contradictory. Therefore, this retrospective cohort analysis aimed to clarify whether there was a difference in overall survival...
Autores principales: | Moeller, Miriam, Schaedlich, Florian, Schuette, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661558/ https://www.ncbi.nlm.nih.gov/pubmed/36355617 http://dx.doi.org/10.1177/10732748221126949 |
Ejemplares similares
-
Survivin knockdown induces senescence in TTF-1-expressing, KRAS-mutant lung adenocarcinomas
por: Sumi, Toshiyuki, et al.
Publicado: (2018) -
TTF1 Expression in Pulmonary Metastatic Rectal Adenocarcinoma
por: Aversa, Sara, et al.
Publicado: (2018) -
The Relationship between TTF-1 Expression and EGFR Mutations in Lung Adenocarcinomas
por: Shanzhi, Wan, et al.
Publicado: (2014) -
KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis
por: Lohinai, Zoltan, et al.
Publicado: (2017) -
The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation
por: Radeczky, Peter, et al.
Publicado: (2021)